Market Research Report
North America Electronic Skin Patches Market Forecast 2021-2028
|Published by||Inkwood Research||Product code||980647|
|Published||Content info||152 Pages
Delivery time: 2-3 business days
|North America Electronic Skin Patches Market Forecast 2021-2028|
|Published: January 7, 2021||Content info: 152 Pages||
The North America electronic skin patches market is projected to grow with a CAGR of 16.24%, over the forecast years of 2021 to 2028. The growing incidence of chronic and lifestyle-associated diseases, including cardiovascular conditions and diabetes, and the rising awareness about the importance of early diagnosis, primarily fuel the region's market growth.
The North America electronic skin patches market growth is assessed by evaluating Canada and the United States. According to the 2019 Diabetes Canada report, less than half of all Canadians can identify the early warning signs of diabetes. However, only 33% are aware that stroke is a significant complication of the chronic condition, with 40% identifying heart disease as a complication. The increasing rate of obesity in Canada, results in surging lifestyle-associated diseases, therefore augmenting the demand for monitoring and treatment of conditions linked to the disease.
Conversely, the country's market is further attributed to the growing geriatric population, as well as the prominence of point-of-care technology, in order to manage chronic conditions. The increasing penetration of tablets, mobile platforms, and smartphones, in addition to the inclination towards personal health and fitness, propels Canada's market growth. For instance, as per the Future of Connected Healthcare Reporting Canadian's Perspective on the Healthcare System, in association with HEC Montreal and CEFRIO, nearly 24% of Canadians utilize smartphone devices to track well-being and health conditions. As a result, these factors are projected to drive the country's market growth, during the forecast period.
Key players operating in the market are, DexCom Inc, MC10 Inc, General Electric Company, Abbott Laboratories, etc.